Sodexo S.A.:戦略・SWOT・企業財務分析

◆英語タイトル:Sodexo S.A. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA8014925
◆発行会社(調査会社):MarketLine
◆発行日:2017年11月10日
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:消費財
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Sodexo S.A. – Strategy, SWOT and Corporate Finance Report
Summary

Sodexo S.A. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Sodexo S.A. (Sodexo or “the company”) is a provider of diversified outsourcing services, including on-site services, benefits and rewards services, and personal and home services. The company primarily operates in North America, the UK and Ireland, and Europe. It is headquartered in Issy-les-Moulineaux, France.

Scope

- Detailed information on Sodexo S.A. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Sodexo S.A. in the form of a SWOT analysis
- An in-depth view of the business model of Sodexo S.A. including a breakdown and examination of key business segments
- Intelligence on Sodexo S.A.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Sodexo S.A., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Sodexo S.A. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Sodexo S.A. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Sodexo S.A.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Sodexo S.A.: Company Overview
Sodexo S.A.: Overview and Key Facts
Sodexo S.A.: Overview
Sodexo S.A.: Key Facts
Sodexo S.A.: Key Employees
Sodexo S.A.: Key Employee Biographies
Sodexo S.A.: Major Products and Services
Sodexo S.A.: Company History
Sodexo S.A.: Management Statement
Sodexo S.A.: Locations and Subsidiaries
Sodexo S.A.: Key Competitors
Sodexo S.A.: Company Analysis
Sodexo S.A.: Business Description
Sodexo S.A.: SWOT Analysis
Sodexo S.A.: SWOT Overview
Sodexo S.A.: Strengths
Sodexo S.A.: Weaknesses
Sodexo S.A.: Opportunities
Sodexo S.A.: Threats
Sodexo S.A.: Corporate Financial Deals Activity
Sodexo S.A.: Financial Deals Overview
Sodexo S.A.: Targets and Partners
Sodexo S.A.: Top Deals 2013 – 2017YTD*
Sodexo S.A.: Advisors
Sodexo S.A.: Top Legal Advisors
Sodexo S.A.: Mergers and Acquisitions
Sodexo S.A.: Corporate Venturing
Sodexo S.A.: Partnership
Sodexo S.A.: Divestments
Sodexo S.A.: Recent Developments
Sodexo S.A.: News and Events Summary
Sodexo S.A.: Contracts
Sodexo S.A.: Corporate Governance
Sodexo S.A.: Financial Deals
Sodexo S.A.: IT Spending Announcements
Sodexo S.A.: Red Flags/DistressSignals
Sodexo S.A.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Sodexo S.A.: Key Facts
Table 2: Sodexo S.A.: Key Employees
Table 3: Sodexo S.A.: Locations and Subsidiaries
Table 4: Sodexo S.A.: Key Competitors
Table 5: Sodexo S.A.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Sodexo S.A.: M&A Activity by Geography (TTM*)
Table 7: Sodexo S.A.: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 8: Sodexo S.A.: Targets and Partners
Table 9: Sodexo S.A.: Top Deals 2013 - 2017YTD*
Table 10: Sodexo S.A.: Legal Advisor Ranking by Value (US$m)
Table 11: Sodexo S.A.: M&A Volume and Value Trend (2013 - YTD*2017)
Table 12: Sodexo S.A.: M&A Activity by Geography (2013 - YTD*2017)
Table 13: Sodexo S.A.: Corporate Venturing Volume and Value Trend (2013 - YTD*2017)
Table 14: Sodexo S.A.: Corporate Venturing by Geography (2013 - YTD*2017)
Table 15: Sodexo S.A.: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 16: Sodexo S.A.: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 17: Sodexo S.A.: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 18: Sodexo S.A.: Divestments by Geography (2013 - YTD*2017)
Table 19: Sodexo S.A.: News and Events Summary
Table 20: Sodexo S.A.: Contracts
Table 21: Sodexo S.A.: Corporate Governance
Table 22: Sodexo S.A.: Financial Deals
Table 23: Sodexo S.A.: IT Spending Announcements
Table 24: Sodexo S.A.: Red Flags/DistressSignals
Table 25: Sodexo S.A.: Strategy and Operations

★海外企業調査レポート[Sodexo S.A.:戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Madhya Pradesh Power Generating Company Ltd:企業の発電所・SWOT分析2018
    Madhya Pradesh Power Generating Company Ltd - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, info …
  • Pioneer Natural Resources Co (PXD):企業の財務・戦略的SWOT分析
    Pioneer Natural Resources Co (PXD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Kaken Pharmaceutical Co Ltd (4521):製薬・医療:M&Aディール及び事業提携情報
    Summary Kaken Pharmaceutical Co Ltd (Kaken Pharma) is a pharmaceutical company that conducts research and develops drugs, agrochemicals, medical equipment and animal health products. The company offers solutions in the fields of orthopedics, dermatology, immunology, inflammation, allergies, fungal i …
  • Omega Pharma NV:企業の戦略的SWOT分析
    Omega Pharma NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • 21st Century Oncology Inc:企業の戦略的SWOT分析
    21st Century Oncology Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Kobe Steel, Ltd.:戦略・SWOT・企業財務分析
    Kobe Steel, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kobe Steel, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Pharmsynthez (LIFE):製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmsynthez is a pharmaceutical company that manufactures and markets generic active pharmaceutical ingredients. The company offers production and sales of both officinal medicines (original OM) and active pharmaceutical ingredients (API). It offers drugs such as vazostenon, glaumax, cathal …
  • Hansen Medical, Inc.:企業のM&A・事業提携・投資動向
    Hansen Medical, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hansen Medical, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • First Gen Corporation:発電所・企業SWOT分析
    First Gen Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employe …
  • Team Health Holdings Inc-製薬・医療分野:企業M&A・提携分析
    Summary Team Health Holdings Inc (TeamHealth) is a healthcare organization that offers patient care services. The organization’s practice areas include emergency medicine, anesthesiology, hospital medicine, hospital medicine subspecialties, ambulatory care, post-acute care and behavioral health serv …
  • Medrobotics Corp:製品パイプライン分析
    Summary Medrobotics Corp (Medrobotics), formerly Cardioborobotics Inc is a medical device company that develops flexible robot platforms for single-site surgical and interventional applications. The company provides flex robotic systems and flex retractor systems. Its flexible robot platform contain …
  • Snam S.p.A. (SRG):電力:M&Aディール及び事業提携情報
    Summary Snam S.p.A. (Snam) is an integrated midstream energy company. The company, through its subsidiaries, carries out the regasification, transportation, storage and supply of natural gas. Snam Rete Gas, its subsidiary, transports natural gas; GNL Italia conducts regasification; and Stogit stores …
  • KSK Energy Ventures Ltd (KSK):企業の財務・戦略的SWOT分析
    KSK Energy Ventures Ltd (KSK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Xbrane Biopharma AB (XBRANE):製薬・医療:M&Aディール及び事業提携情報
    Summary Xbrane Biopharma AB (Xbrane), formerly Xbrane Bioscience AB is a biopharmaceutical company that develops and manufactures complex generic products. The company's product portfolio includes biosimilars and long acting injectables developed for people suffering from critical diseases. It combi …
  • Mannai Corporation QSC:企業のM&A・事業提携・投資動向
    Mannai Corporation QSC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mannai Corporation QSC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Poudre Valley Rural Electric Association, Inc.:発電所・企業SWOT分析
    Poudre Valley Rural Electric Association, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, i …
  • Bovie Medical Corp (BVX)-医療機器分野:企業M&A・提携分析
    Summary Bovie Medical Corp (Bovie Medical) is a manufacturer of medical devices and supplies. The company offers J-plasma, electrosurgery, veterinary products, acudop ii dopplers, clearspec speculum, colposcopes, cryosurgery, dermascout dermatoscope, medical lights, nerve locators, ophthalmic produc …
  • Centre for Commercialization of Regenerative Medicine:製薬・医療:M&Aディール及び事業提携情報
    Summary Centre for Commercialization of Regenerative Medicine (CCRM) is a healthcare service provider that offers cell reprogramming and engineering, cell manufacturing, biomaterials and devices manufacturing, and protocol development services. The center harnesses the power of stem cells, biomateri …
  • GlaxoSmithKline Plc (GSK):医療機器:M&Aディール及び事業提携情報
    Summary GlaxoSmithKline Plc (GSK) is a healthcare company, which focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of HIV, respiratory, cancer, immuno-inflammation, anti-virals, central nervo …
  • Global Blood Therapeutics Inc (GBT):企業の財務・戦略的SWOT分析
    Summary Global Blood Therapeutics Inc (GBT) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes novel oral medicines for the treatment of grievous blood-based disorders. The company's lead drug candidate GBT440 is an oral, small molecule drug for the treatment o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆